Although the anti-CX3CL1 antibody did not impair cell viability, the number of induced HSPCs was decreased when CX3CL1 was blocked, suggesting that CX3CL1 likely promotes HE cell transition in vitro (Fig. 2j, k). The gene discussed is CX3CL1; the disease is hereditary elliptocytosis.